0000899243-15-003121.txt : 20150814
0000899243-15-003121.hdr.sgml : 20150814
20150814073048
ACCESSION NUMBER: 0000899243-15-003121
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150812
FILED AS OF DATE: 20150814
DATE AS OF CHANGE: 20150814
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001114220
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 134087132
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
STREET 2: .
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-531-5965
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Neylan John F.
CENTRAL INDEX KEY: 0001640447
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30929
FILM NUMBER: 151052531
MAIL ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-08-12
0
0001114220
KERYX BIOPHARMACEUTICALS INC
KERX
0001640447
Neylan John F.
C/O KERYX BIOPHARMACEUTICALS, INC.
750 LEXINGTON AVENUE
NEW YORK
NY
10022
0
1
0
0
Chief Medical Officer
Common Stock
2015-08-12
4
P
0
10000
6.20
A
55000
D
The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
Includes 45,000 shares of restricted stock.
/s/ Brian Adams
2015-08-14